Dr. Fernando Fumagalli graduated in pharmacy and obtained his PhD in Pharmaceutical Sciences from the University of São Paulo (FCFRP-USP, Brazil) in the group of Prof. Flavio da Silva Emery. For a short period of his PhD, he worked with C‒H activations reactions at Prof. Lutz Ackermann group (University of Göttingen, Germany). Since 2019, he has been a Medicinal Chemistry professor at the Federal University of Santa Maria (UFSM, Brazil) and started his research group LaComBS (Synthetic and Bioactive Compounds Laboratory). His interests include synthesis and chemical functionalization of underexplored heterocyclic cores, focusing on developing new anticancer and anti-infective agents.